Control of the HIV infection dynamics with a reduced second order model

Proceedings of the American Control Conference

Volumn , Issue , 2007, Pages 4083-4088

  Chang, H ^a   Astolfi, A ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; COMPUTATIONAL METHODS; COMPUTER SIMULATION; DRUG DELIVERY; DRUG DOSAGE; DYNAMICS; PARAMETER ESTIMATION; POLYNOMIAL APPROXIMATION; STEEL ANALYSIS;

(001) PARAMETER; (LIQUID + LIQUID) EQUILIBRIUM; DYNAMIC PROCESSES; HIGH-ORDER MODELING; HIGHER-ORDER DYNAMICS; HIV INFECTION MODEL; HIV INFECTIONS; INITIAL STATES; NEW METHODS; REDUCED-ORDER-MODEL (ROM); SECOND-ORDER MODELS; STATE OBSERVATION;

MODAL ANALYSIS;

EID: 39549094054     PISSN: 07431619     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ACC.2007.4282250     Document Type: Conference Paper

References (16)

1. M. Nowak and R. May, Virus Dynamics. New York, 2000.
2. D. Wodarz and M. Nowak, "Specific therapy regimes could lead to long-term immunological control of HIV," Proc. of National Academy Science, vol. 96, no. 25, pp. 14464-14469, 1999.
3. D. Wodarz, "Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance," J. of Theoretical Biology, vol. 213, pp. 447-459, 2001.
4. D. Wodarz and M. Nowak, "Mathematical models of HIV pathogenesis and treatment," BioEssays, vol. 24, pp. 1178-1187, 2002.
5. R. Zurakowski and A. Teel, "A model predictive control based scheduling method for HIV therapy," J. of Theoretical Biology, vol. 238, pp. 368-382, 2006.
6. H. Chang and A. Astolfi, "Immune response's enhancement via controlled drug scheduling," submitted to IEEE Trans. Automation Science and Engineering.
7. H. Chang, N. Jo, and H. Shim, "Gradual reduction of drug dosage on an HIV infection model with helper-independent CTL," Journal of Control, Automation and System Engineering, vol. 10, no. 12, pp. 1148-1154, 2004.
8. R. Zurakowski, Exploiting Immune Response Dynamics in HIV Therapy. Univ. of California, Santa Barbara, 2004, ph.D Dissertation.
9. K. Alcorn, A. Poppa, and M. Nicholson, HIV and AIDS treatments directory, 16th ed. National AIDS Manual, 1999.
10. H. Chapel, M. Haeney, S. Misbah, and N. Snowden, Essentials of clinical immunology, 4th ed. Blackwell Science, 1999.
11. H. Chang and A. Astolfi, "Control of HIV infection dynamics," submitted to IEEE Control Syst. Mag.
12. M. Sande and P. Volberding, The medical management of AIDS, 6th ed. W.B. Saunders, 1999.
13. L. Herzenberg, D. Parks, B. Sahaf, O. Perez, M. Roederer, and L. Herzenberg, "The history and future of the fluorescence activated cell sorter and flow cytometry: A view from Stanford," Clinical Chemistry, vol. 48, no. 10, pp. 1819-27, 2002.
14. H. Chang, H. Shim, and J. Seo, "Control of immune response of HIV infection model by gradual reduction of drug dose," in Proc. of Conference on Decision and Control, 2004, pp. 1048-1054.
15. H. Chang, N. Jo, and H. Shim, "An applicationn of gradual reduction of drug dose to HIV infection model in consideration of drug resistance and drug dose," in Proc. of SICE-ICASE International Joint Conference, 2006, pp. 5236-5241.
16. H. Shim, N. Jo, H. Chang, and J. Seo, "Feasibility of achieving long-term non-progressor for AIDS patient and nvba-stability-based treatment," submitted to IEEE Trans. Automat. Contr.